Molina Healthcare denied your IVIG and immunoglobulin? Here is what to do next

Why Molina Healthcare denies IVIG and immunoglobulin

Molina Healthcare is concentrated in Medicaid managed care, with smaller marketplace and Medicare Advantage footprints. Appeal pathways depend heavily on the underlying line of business and the state Medicaid agency that contracts with Molina.

For IVIG and immunoglobulin specifically: Intravenous and subcutaneous immunoglobulin (IVIG, SCIG) is expensive, infused repeatedly, and reviewed against a short list of accepted diagnoses. Denials say 'not medically necessary' or 'experimental' for the specific condition, or move the drug to a different benefit or site of care.

What Molina Healthcare denies for IVIG and immunoglobulin

The IVIG and immunoglobulin services most often denied:

• IVIG for CIDP, myasthenia gravis, dermatomyositis, or autoimmune encephalitis
• Continuation after the initial authorization period when response is not documented
• Dose or frequency above the policy's stated range
• Site-of-care changes: hospital outpatient infusion moved to home or a standalone center
• Subcutaneous immunoglobulin when the plan prefers intravenous

Why IVIG and immunoglobulin claims get denied

A typical Molina Healthcare IVIG and immunoglobulin denial almost always cites one of these reasons. Each one maps to a specific rebuttal in the appeal:

• Diagnosis not on the plan's list of covered indications
• Required baseline labs (immunoglobulin levels, vaccine response, nerve conduction studies) not in the record
• No documented failure of first-line therapy where the policy requires it
• Response to prior IVIG cycles not documented in measurable terms
• Plan classifies the use as experimental or investigational

The Molina Healthcare appeal process

Appeal levels: Plan internal appeal, then state Medicaid fair hearing for Medicaid lines. Marketplace: internal then federal external review. Medicare Advantage: federal 5-level ladder.

Carrier timing: Medicaid filing windows are state-specific, commonly 60-120 days from the action notice. Continuation-of-benefits typically requires filing within 10 days. Marketplace: 180 days internal, 4 months external.

IVIG timing: Ongoing infusions make most IVIG appeals urgent: request expedited review and expect a decision within 72 hours (29 CFR 2560.503-1(f)(2)(i); 42 CFR 422.584 for Medicare Advantage). Internal appeal filing window: at least 180 days for commercial and employer plans; 65 days for Medicare Advantage; 60 days for Part D redetermination (42 CFR 423.582). External review must be requested within 4 months of the final internal denial for ACA-covered plans.

What we know about Molina Healthcare: Molina appeals are most often won at the state fair-hearing stage. We preserve continuation-of-benefits where the timing permits and brief the case to the state's administrative law judge.

Common Molina Healthcare denial patterns for IVIG and immunoglobulin

• State Medicaid fair-hearing escalation. Molina Medicaid denials must first run through the plan's internal grievance and appeal process. After plan-level denial, the member has the right to a state Medicaid fair hearing, a separate administrative track that frequently overturns prior-auth and medical-necessity denials.
• Continuity-of-care protections. Medicaid rules generally require continuation of previously authorized services pending the outcome of a timely-filed appeal. Members who file within the state's continuation window (often 10 days from the action notice) preserve services during the appeal.
• EPSDT-based denials in pediatric cases. For Molina members under 21, federal EPSDT (Early and Periodic Screening, Diagnostic, and Treatment) requirements broaden coverage beyond the adult benefit. Many pediatric denials reverse on appeal once the EPSDT framework is cited.

How to win your Molina Healthcare IVIG and immunoglobulin appeal

Strategy for IVIG and immunoglobulin: Request the plan's immunoglobulin policy and the reviewer's specialty. Have the treating specialist write to each criterion: diagnosis with supporting labs or electrodiagnostic studies, prior therapies and results, measurable response to IVIG, and dosing rationale. For off-label uses, attach the guideline or peer-reviewed evidence the specialist relies on and identify it accurately. If the denial is 'experimental', the external review process specifically covers that determination (45 CFR 147.136(d)).

Filed against Molina Healthcare, that strategy rides on this procedural spine:

1. Procedural-rights anchor. Every Molina Healthcare denial triggers ERISA § 503 or 45 C.F.R. § 147.136 procedural rights. The cover letter invokes these in the opening paragraph to lock the timeline and force criteria disclosure.
2. Criteria-disclosure demand. Molina Healthcare frequently denies on "not medically necessary" without disclosing the clinical criteria applied. Once disclosed, those criteria become the rebuttal map.
3. Controlling-standard citation. Plans compare the diagnosis to their immunoglobulin policy, which typically lists FDA-labeled indications (primary immunodeficiency, immune thrombocytopenia, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy, Kawasaki disease, and others) and selected off-label uses supported by published evidence. Medicare Part B covers immunoglobulin for primary immunodeficiency at home under 42 CFR 410.10 and the home IVIG benefit; other indications follow local coverage determinations in the Medicare Coverage Database. Plan criteria must be disclosed on request (29 CFR 2560.503-1(m)(8); 45 CFR 147.136).
4. Treating-provider attestation. A letter from the treating physician addressing each criterion in Molina Healthcare's own policy language. This is the single strongest evidentiary element.
5. Requested action. A specific demand to reverse the IVIG and immunoglobulin denial and approve the service, not a general "please reconsider."

Documents you'll need for your Molina Healthcare IVIG and immunoglobulin appeal

• The denial letter naming the criterion or policy applied
• Specialist's notes with diagnosis, labs, and electrodiagnostic or imaging results
• Record of prior therapies and outcomes
• Infusion records showing dose, frequency, and documented response
• The plan's immunoglobulin policy (request it in writing)

What a IVIG and immunoglobulin appeal can recover

Typical recovery for IVIG and immunoglobulin cases runs Immunoglobulin is among the most expensive recurring therapies; a denied course commonly represents thousands of dollars per infusion in billed charges.. The exact figure depends on the specific service and your plan's contracted rates.

Molina Healthcare IVIG and immunoglobulin appeals: frequently asked questions

What Apellica does for Molina Healthcare IVIG and immunoglobulin appeals

We file appeals against Molina Healthcare specifically configured to its internal review process. Every IVIG and immunoglobulin appeal embeds the criteria-disclosure demand, the procedural-rights anchor, the controlling-standard citation above, treating-provider attestation language, and the peer-reviewed evidence relevant to the denied service.

Cost: $0 upfront. We work on contingency for Molina Healthcare appeals, if the appeal succeeds, we collect a percentage of the recovered claim value. If it fails, you owe nothing.

Related Molina Healthcare guides

• Molina Healthcare surgery denials appeal guide
• Molina Healthcare mri and imaging denials appeal guide
• Molina Healthcare medication and prescription denials appeal guide
• Molina Healthcare medicare denials appeal guide

IVIG and immunoglobulin guides for other carriers

• UnitedHealthcare IVIG and immunoglobulin appeal guide
• Aetna (CVS Health) IVIG and immunoglobulin appeal guide
• Cigna (Evernorth) IVIG and immunoglobulin appeal guide
• Anthem / BlueCross BlueShield IVIG and immunoglobulin appeal guide